Deanna’s Hope
The future of ALS treatment with the Deanna Protocol
When on the Deanna Protocol, Deanna’s physical condition stopped deteriorating and she stabilized (which is unheard of in ALS patients who are progressing quickly). Deanna was doing so well on the Deanna Protocol that other ALS patients who knew her began asking Dr. Tedone to share information with them on what Deanna was taking. Others with ALS began seeing incredible results and began referring friends and writing about their improvements on ALS related blogs and websites. Word of mouth continued to spread and, now, there are over 6,000 individuals with ALS on the Deanna Protocol worldwide.
Throughout the years, Dr. Tedone and researchers at various universities have tested and refined the protocol, resulting in the Deanna Protocol we have today — a patented formulation with a specific ratio of Alpha‑Ketoglutarate (AKG) and Gamma‑Aminobutyric Acid (GABA). These compounds occur naturally in the body, but people with ALS require higher levels to support the Krebs cycle, the energy‑producing process that keeps their nerve cells functioning. Arginine is added to balance the acidity of AKG, making the formula more palatable and allowing for better absorption. In this way, the Deanna Protocol acts like a special fuel, helping to keep the cellular engine running when disease threatens its performance.